ALDH1A1 and head and neck squamous cell carcinoma: Furthermore, high ALDH1 immunoexpression, regardless of the assessed tumor area, was associated with an unfavorable outcome, suggesting this marker could be used as an indicator of worst prognosis for patients with HNSCC (24,27).